in PAD patients requiring minor amputation. The aim of this study was to investigate outcomes associated with GA, regional anesthesia (RA), and local anesthesia (LA) in minor foot amputation procedures.
Methods:
The American College of Surgeons National Surgical Quality Improvement Program between 2005 and 2012 was queried using Current Procedural Terminology codes indicating podiatry amputation procedures for patients with a history of PAD. Propensity score matching was used to balance comorbidities between the GA, RA, and LA cohorts. Operative variables and postoperative complications were compared using c 2 tests for categorical variables and paired t-testing for continuous variables.
Results: A total of 2934 minor amputations were identified from the database query. Propensity score matching was conducted using baseline characteristics to account for covariates to minimize selection bias. The GA cohort and RA and LA cohorts were similar with respect to wound class (P ¼ .43), intraoperative cardiopulmonary resuscitation (1.4% vs 2.4%, P ¼ .30), hospital stay (14.8 days vs 13.3 days; P ¼ .06), and 30-day mortality (3.8% vs 2.9%; P ¼ .44; Table I ). Transmetatarsal amputations composed the majority in this analysis (92.7%). Rates of postoperative myocardial infarction (1.4% vs 1.4%; P ¼ 1.00) and postoperative stroke (0.2% vs 0.2%; P ¼ 1.00) were also similar between groups. However, rates of postoperative wound disruption (1.9% vs 0.2%; P ¼ .02), pneumonia (4.1% vs 0.5%; P < .02), prolonged intubation >48 hours (1.9% vs 0.2%; P ¼ .02), and septic shock (2.6% vs 0.7%; P ¼ .03) were significantly higher in the GA group (Table II) .
Conclusions: Whereas GA was found to have similar perioperative cerebrovascular outcomes, RA or LA was favorable for pulmonary and woundrelated outcomes. RA or LA should be primarily considered over GA for minor foot amputation. Patients with a pre-existing lung condition would also benefit from RA or LA.
Author Disclosures: M. Walsh: Nothing to disclose; S. Lim: Nothing to disclose; L. Gil: Nothing to disclose; P. Halandras: Nothing to disclose; C. Bechara: Nothing to disclose; B. Aulivola: Nothing to disclose; P. Crisostomo: Nothing to disclose. A 67-year-old man with a recent above-knee amputation surgery presented to the emergency department with fever, tachycardia, hypotension, altered mental status, and a necrotic, foul-smelling amputation stump. He was taking warfarin for atrial fibrillation with an initial international normalized ratio of 6.1. Examination revealed skin crepitus suggestive of an anaerobic infection. Because of his progressive hemodynamic instability and coagulopathy, we performed cryoamputation using dry ice in the intensive care unit for resuscitation and correction of his coagulopathy. The following day, he was hemodynamically stable and taken to surgery for guillotine resection of the frozen infected stump. Two days later, the amputation stump was débrided, and a higher above-knee amputation was reconstructed with viable skin and muscle. At 4 months of follow-up, he was undergoing fitting for an above-knee amputation prosthesis. The initial tissue cultures were positive for Enterococcus faecalis, Clostridium ramosum, Staphylococcus aureus, and group C beta streptococci. Although rarely used, cryotherapy can be useful in a setting of severe infection and an unstable patient. In this case, severe coagulopathy and rapidly progressive infection of the stump were critical factors in the selection of cryotherapy. Used properly, the degree of skin and tissue damage can be limited to the site of the infection, preserving enough of the remaining limb to salvage the amputation stump. Objective: Few data exist to accurately describe the difference in characteristics, management, and outcomes of patients with premature peripheral arterial disease (PPAD), defined as patients <50 years old at the time of intervention. Our goal was to use Vascular Quality Initiative (VQI) data to investigate differences between PPAD patients and non-PPAD patients who had lower extremity vascular interventions.
Cryoamputation of a Severely
Methods: All VQI patients from the infrainguinal bypass and peripheral vascular intervention (PVI) modules between 2010 and 2015 were included. Patients were divided into two groups: <50 years old (PPAD group) and $50 years old (non-PPAD group). The patients' demographics, comorbidities, procedure indications, and outcomes at longterm follow-up were compared. Outcomes analyzed included patency, limb salvage, symptom recurrence, need for reintervention, and survival. Long-term follow-up is defined in the VQI as 9 to 21 months.
Results: Data from 5411 PPAD patients and 99,630 non-PPAD patients were analyzed. PPAD patients were more commonly African American, female, and smokers at the time of the procedure (all P < .01). PPAD patients underwent infrainguinal bypass more frequently than non-PPAD patients did (29.1% vs 25.2%; P < .01). PPAD patients undergoing infrainguinal bypass had higher rates of postoperative revision (21.5% vs 13.2%; P > .001) and major amputation (9.6% vs 6.5%; P < .001; Table) . For PPAD patients undergoing PVI, rates of major amputation were higher as well (6.6% vs 4.6%; P < .001; Table) . On adjusting for significant comorbidities, medications, and previous interventions, PPAD patients were still found to have significantly increased odds of major amputation after infrainguinal bypass (odds ratio, 1.45; P < .004) and PVI (odds ratio, 1.57; P < .001).
Conclusions: PPAD patients experienced higher rates of postoperative revision after infrainguinal bypass and major amputation after both infrainguinal bypass and PVI. Although limited data sets such as the VQI do not lend themselves to more discrete examination, it seems reasonable to avoid lower extremity intervention in PPAD patients until it is deemed urgent or emergent because of poorer outcomes in this group.
Author Disclosures: T. Yoo: Nothing to disclose; D. Chou: Nothing to disclose; S. Prakash: Nothing to disclose; B. Satiani: Nothing to disclose; J. E. Starr: Nothing to disclose. Objective: Peripheral arterial disease (PAD) affects nearly 8.5 million patients in the United States according to the Centers for Disease Control and Prevention. Although lifestyle modification and medical management can delay the rate of disease progression, approximately 5% of patients with PAD will eventually require revascularization. The most common complication of lower extremity bypass is surgical site infection (SSI), which can lead to prolonged hospital stays, additional procedures, and additive patient and hospital costs.
Variables Predicting Surgical Site Infection in
Methods: We analyzed data from 10,741 patients with PAD treated with open femoropopliteal bypass surgery collected from the National Surgical Quality Improvement Program (NSQIP) database from 2010 to 2016 using International Classification of Diseases and Current Procedural Terminology codes. c 2 tests and t-tests were used to compare preoperative risk factors. Logistic regression analysis was then used to correct for preoperative comorbidities. Analysis of strength of our model was performed using Hosmer-Lemeshow goodness of fit testing and receiver operating characteristic analysis.
Results: Overall in the NSQIP cohort, we found that the overall rate of any infection was 9.3%. Reported wound disruption was 1.7%. Superficial SSIs made up most of this number at 6.6%; deep incisional SSI was 2.2%, and organ/space SSI was 0.6%. Predictably, overall the strongest predictor of any SSI was the presence of diabetes, with a 29.5% increase in SSI with non-insulin dependence (adjusted odds ratio [aOR], 1.29; 95% confidence interval [CI], 1.09-1.54; P ¼ .004) and a 68.3% increase with insulin dependence (aOR, 1.68; 95% CI, 1.44-1.96; P < .001). A history of chronic obstructive pulmonary disease was the second most important factor with a 43.6% increase in incidence of SSI (aOR, 1.44; 95% CI, 1.21-1.71; P < .001). Surprisingly, a history of smoking within 1 year did not dramatically increase the risk of SSI, with only a 19.4% increase in incidence (aOR, 1.19; 95% CI, 1.04-1.36; P ¼ .01).
Conclusions: Femoropopliteal bypass is the "gold standard" for treatment of femoral PAD. With the prevalence of endovascular treatment, analysis of the most recent NSQIP data finds some interesting trends as to risk factors for development of SSI with femoropopliteal bypass. The overall rate of SSI is much higher than in other reported studies in the literature at 9.3%, which might be a contribution of endovascular treatment for healthier patients.
Author Disclosures: C. Das: Nothing to disclose; M. Nazzal: Nothing to disclose; M. Adair: Nothing to disclose; S. Markowiak: Nothing to disclose; M. Omar: Nothing to disclose; S. Gregory: Nothing to disclose. Objective: Interventional strategies for acute limb ischemia continue to evolve. Most studies have focused on the comparison between thrombolytic therapy and surgical revascularization. However, limited data exist on the use of novel vacuum-assisted thrombectomy (VAT) devices. The purpose of this study was to evaluate the outcomes of patients who have undergone VAT at our institution. Lower extremity bypass occlusion 11 15
Lower extremity thromboembolism 37 51
Lower extremity stent occlusion 17 23
Upper extremity embolism 1 1.4
